Pharming Group N.V.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $145.3M | $54.9M | $61.7M | $207.3M | $191.9M | $205.2M | $74.3M |
| Accounts Receivable | $54.7M | $54.8M | $46.2M | $27.6M | $30.0M | $35.9M | $28.9M |
| Inventory | $64.9M | $55.7M | $56.8M | $42.3M | $27.3M | $21.2M | $16.2M |
| Total Current Assets | $299.5M | $278.4M | $316.3M | $277.5M | $249.4M | $263.2M | $119.4M |
| Property, Plant & Equipment | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $500.0M | $400.0M | $462.9M | $425.8M | $397.3M | $418.5M | $255.9M |
| Liabilities | |||||||
| Accounts Payable | $105.9M | $66.6M | $72.5M | $54.5M | $42.5M | $47.7M | $40.6M |
| Total Current Liabilities | $115.8M | $73.8M | $78.0M | $59.7M | $46.8M | $76.8M | $114.3M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $222.9M | $178.9M | $244.1M | $221.2M | $204.4M | $235.0M | $138.5M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-273.0M | $-275.5M | $-265.3M | $-256.4M | $-273.2M | $-295.6M | $-340.7M |
| Total Stockholders' Equity | $277.1M | $221.1M | $218.8M | $204.6M | $192.9M | $183.4M | $117.4M |